STOCK TITAN

10x Genomics to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

10x Genomics (Nasdaq: TXG) will participate in the Morgan Stanley 19th Annual Global Healthcare Conference on September 13th at 2:45 p.m. ET. The presentation will be accessible via a live and archived webcast through the company’s Investors’ section. 10x Genomics is a leader in life science technology, providing innovative solutions for analyzing biological systems. Their products are recognized globally, with over 2,800 research citations and a strong patent portfolio of more than 1,150 patents and applications.

Positive
  • None.
Negative
  • None.

PLEASANTON, Calif., Aug. 31, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the Morgan Stanley 19th Annual Global Healthcare Conference.

10x Genomics’ management is scheduled to present on Monday, September 13th, at 2:45 p.m. Eastern Time/11:45 a.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.10xgenomics.com/.

About 10x Genomics

10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. The company’s integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers around the world including in all of the top 100 global research institutions as ranked by Nature in 2020 based on publications and all of the top 20 global pharmaceutical companies by 2020 research and development spend and have been cited in over 2,800 research papers on discoveries ranging from oncology to immunology and neuroscience. The company’s patent portfolio comprises more than 1,150 issued patents and patent applications.

Disclosure Information

10x Genomics uses filings with the Securities and Exchange Commission, its website (www.10xgenomics.com), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Media Contact:

media@10xgenomics.com

Investor Relations Contact:

investors@10xgenomics.com


FAQ

When is 10x Genomics presenting at the Morgan Stanley Healthcare Conference?

10x Genomics will present on September 13th at 2:45 p.m. Eastern Time.

How can I access the 10x Genomics conference presentation?

The presentation can be accessed via a live and archived webcast on the company's Investors’ section.

What is the significance of 10x Genomics in life sciences?

10x Genomics is recognized for its advanced solutions that help analyze complex biological systems, having been cited in over 2,800 research papers.

How many patents does 10x Genomics hold?

10x Genomics has a patent portfolio comprising more than 1,150 issued patents and patent applications.

What Event is 10x Genomics participating in on September 13th?

10x Genomics is participating in the Morgan Stanley 19th Annual Global Healthcare Conference.

10x Genomics, Inc.

NASDAQ:TXG

TXG Rankings

TXG Latest News

TXG Stock Data

1.69B
103.99M
2.15%
96.03%
5.67%
Health Information Services
Laboratory Analytical Instruments
Link
United States of America
PLEASANTON